Skip to main content
SpringerLink
Log in

Auswirkungen der COPD-Therapie auf das Patientenüberleben

TORCH-Studie (TOwards a Revolution in COPD Health)

Impact of COPD therapy on patient survival: the TORCH study (TOwards a Revolution in COPD Health)

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Barnes P (2007) Prevention of death in COPD. N Engl J Med 356:2211–2214

    Article  PubMed  CAS  Google Scholar 

  2. Decramer M, Celli B, Tashkin DP et al. (2004) Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial. COPD 1: 303–312

    Article  PubMed  Google Scholar 

  3. Kardos P, Wencker M, Glaab T, Vogelmeier C (2007) Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175: 144–149

    Article  PubMed  CAS  Google Scholar 

  4. Rabe KF (2007) Treating COPD – the TORCH trial, p-values, and the Dodo. N Engl J Med 356: 851–854

    Article  PubMed  CAS  Google Scholar 

  5. Vestbo J, TORCH Study Group (2004) The TORCH (TOwards a Revolution in COPD Health) survival study protocol. Eur Respir J 24: 206–210

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass keine aktuellen, persönlichen finanziellen Verbindungen zu dem Hersteller der in dieser Studie geprüften Pharmaka bestehen. Finanzielle Verbindungen bestehen zu Herstellern von Konkurrenzprodukten (Boehringer Ingelheim, Asche Chiesi).

Author information

Authors and Affiliations

  1. Stuttgart, Deutschland

    S. Nitschmann

  2. Medizinische Klinik III, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Deutschland

    G. Schultze-Werninghaus

Authors
  1. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Schultze-Werninghaus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Schultze-Werninghaus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nitschmann, S., Schultze-Werninghaus, G. Auswirkungen der COPD-Therapie auf das Patientenüberleben. Internist 48, 1450–1452 (2007). https://doi.org/10.1007/s00108-007-1964-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-007-1964-0

Search

Navigation